

"Global CRDMO enabling pharmaceutical R&D and manufacturing services for healthcare innovation"
WuXi AppTec operates as a global pharmaceutical CRDMO, offering integrated research, development and manufacturing services across Asia, Europe and North America. The company supports innovators through every stage of drug development, from early discovery and preclinical testing to clinical trials and commercial production. Its end-to-end platform helps partners advance treatments efficiently. By combining chemistry drug CRDMO, biology discovery and testing capabilities, WuXi AppTec accelerates timelines for breakthrough medicines. The company serves customers in over 30 countries, dedicated to the vision that every drug can be made and every disease can be treated. Patients worldwide benefit from faster access to innovative treatments.


33000
Team Members
2000
Founded
Contract Research
Sector
Hybrid
Work Environment
A world where pharmaceutical innovation faces no technical barriers, where every therapeutic concept can be realised into medicine and every patient can access the treatment they need regardless of disease complexity.
Through a global CRDMO enabling platform, we help our customers and partners discover, develop and manufacture pharmaceuticals and healthcare products to benefit patients globally.